Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 314 participants.

Also called NCT07717216

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 314 participants (planned count) (from the registry)
Sponsor
Weifang Medical University (from the registry)
Registry
  • NCT NCT07717216
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07717216. Randomized; triple masking; primary purpose treatment. Start 2026-09-01 (anticipated); primary completion 2029-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND)
Condition
Stroke, Acute
Condition
Neuroprotection
Condition
Normobaric Hyperoxia
Condition
Endovascular Treatment
Intervention (Drug)
Oxygen (Normobaric Hyperoxia)
Intervention (Drug)
Sham Normobaric Hyperoxia
Intervention (Procedure)
Endovascular Therapy
Lead sponsor
Weifang Medical University (class: other)

Record details

Record id
cardio:ct-nct07717216
Content hash
886edbcbf653c01d7aac492bffd29646100a0a9931e4bc1e0cd117a159faf846